Andrey Kirilchuk

Dr. Andrey Kirilchuk

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Molecules
Verified
Journal Article
Open access
PDF file
HMHamza Mechchate
Hamza Mechchate
IEImane Es-safi
Imane Es-safi
MBMohammed Bourhia
Mohammed Bourhia
AKAndrey Kirilchuk
Andrey Kirilchuk
AMAbdelfattah EL Moussaoui
Abdelfattah EL Moussaoui
DBDalila Bousta
Dalila Bousta
Background: Olea europea L. subsp. europaea var. sylvestris (Mill) Lehr (Oleaster) is a wild endemic olive tree indigenous to the Mediterranean region. Olea europea leaves represent a natural reservoir of bioactive molecules that can be used for therapeutic purposes. Aim of the study: This work was conducted to study antidiabetic and antihyperglycemic activities of flavonoids from oleaster leaves using alloxan-induced diabetic mice. The mode of action of flavonoids against eight receptors that have a high impact on diabetes management and complication was also investigated using molecular docking. Results: During 28 days of mice treatment with doses 25 and 50 mg/kg b.w, the studied flavonoids managed a severe diabetic state (<450 mg/dL), exhibiting a spectacular antidiabetic and antihyperglycemic activity, and improved mice health status compared to diabetic control. The in-silico mode of action of oleaster flavonoids revealed the inhibition of protein tyrosine phosphatase 1B (PTP1B), Dipeptidyl-peptidase 4 (DPP4), α-Amylase (AAM), α-Glucosidase inhibition, Aldose reductase (AldR), Glycogen phosphorylase (GP), and the activation of free fatty acid receptor 1 (FFAR1). Conclusion: The findings obtained in the present work indicate that the flavonoids from the oleaster may constitute a safe multi-target remedy to treat diabetes.

5 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
HMHamza Mechchate
Hamza Mechchate
ROREGIANE COSTA DE OLIVEIRA
REGIANE COSTA DE OLIVEIRA
IEImane Es-safi
Imane Es-safi
EMEmmily Mourao
Emmily Mourao
MBMohamed Bouhrim
Mohamed Bouhrim
AGAndriy Grafov
Andriy Grafov
Leukemia is a group of hematological neoplastic disorders linked to high mortality rates worldwide, but increasing resistance has led to the therapeutic failure of conventional chemotherapy. This study aimed to evaluate in vitro the antileukemic activity and potential mechanism of action of a polyphenolic extract obtained from the seeds of Coriandrum sativum L. (CSP). A methylthiazoletetrazolium assay was performed to assess the CSP cytotoxicity on chronic (K562) and acute (HL60) myeloid leukemia cell lines and on normal Vero cell line. CSP toxicity was also evaluated in vivo using the OECD 423 acute toxicity model on Swiss albino mice. The results demonstrated a remarkable antitumoral activity against K562 and HL60 cell lines (IC50 = 16.86 µM and 11.75 µM, respectively) although no cytotoxicity was observed for the Vero cells or mice. A silico study was performed on the following receptors that are highly implicated in the development of leukemia: ABL kinase, ABL1, BCL2, and FLT3. The molecular docking demonstrated a high affinity interaction between the principal CSP components and the receptors. Our findings demonstrated that CSP extract has remarkable antileukemic activity, which is mainly mediated by the flavonoids, catechins, and rutin, all of which showed the highest binding affinity for the targeted receptors. This study revealed a promising active compound alternative research-oriented biopharmacists to explore.

2 November 2012 in Organometallics
Verified
Journal Article
Closed access
AMAnatoliy P. Marchenko
Anatoliy P. Marchenko
HKHeorgiy N. Koidan
Heorgiy N. Koidan
EZEvgenij Zarudnitskii
Evgenij Zarudnitskii
AHAnastasiya N. Hurieva
Anastasiya N. Hurieva
AKAndrey Kirilchuk
Andrey Kirilchuk
AKAleksandr N. Kostyuk
Aleksandr N. Kostyuk

13 December 2021 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
AMAnatoliy Marchenko
Anatoliy Marchenko
GKGeorgyi Koidan
Georgyi Koidan
AHAnastasiya Hurieva
Anastasiya Hurieva
KSKostiantyn Shvydenko
Kostiantyn Shvydenko
ARAlexander B. Rozhenko
Alexander B. Rozhenko
AKAleksandr Kostyuk
Aleksandr Kostyuk

1 March 2017 in Computational and Theoretical Chemistry
Verified
Journal Article
Closed access
AKAndrey Kirilchuk
Andrey Kirilchuk
ARAlexander B. Rozhenko
Alexander B. Rozhenko
JLJerzy Leszczynski
Jerzy Leszczynski

19 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AAamal amaghnouje
amal amaghnouje
SBSerhii Bohza
Serhii Bohza
NBNathalie Bohdan
Nathalie Bohdan
IEImane Es-safi
Imane Es-safi
AKAndrey Kirilchuk
Andrey Kirilchuk
AGAndriy Grafov
Andriy Grafov
We report the design and synthesis of a new diazepine derivative, 4-(4-methoxyphenyl)-2,3,4,5-tetrahydro-2,3-benzodiazepin-1-one (VBZ102), and the evaluation of its anxiolytic-like profile, memory impairment effect, and toxicity in Swiss mice. VBZ102 was evaluated for central nervous system effects in an open field, light–dark box, and novel object recognition tests under oral administration for acute and sub-acute treatment. We tested the VBZ102 toxicity in mice through a determination of LD50 values and examination of the biochemical and histopathological parameters. The VBZ102 induced an anxiolytic effect at different doses both in the light–dark box and open field tests. Unlike other benzodiazepines (e.g., bromazepam), a sedative effect was noted only after administration of the VBZ102 at 10.0 mg/kg.